$181.65
0.880.49%
In chiusura: -
$181.65
0.000.00%
After hour: Oct 17, 4:00 PM EDT
Comments
Loading...
Ligand Pharmaceuticals Rapporto sugli interessi allo scoperto
LGNDNASDAQ
Report sulle vendite allo scoperto
Il short interest su Ligand Pharmaceuticals Inc (NASDAQ:LGND) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 1.12M a 1.20M. Questo rappresenta il 7.42% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Ligand Pharmaceuticals Corp (XNAS:LGND) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 260.97K azioni scambiate al giorno, ci vorrebbero 4.58 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
1.20M
Vendite allo scoperto %
7.42%
Giorni di copertura
4.58
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
LGND | Ligand Pharmaceuticals Incorpo | 09/30/2025 | 10/09/2025 | 7.42% | 16,113,683 | 1,195,235 | 260,967 | 4.58 | |
LGND | Ligand Pharmaceuticals Incorpo | 09/15/2025 | 09/24/2025 | 6.96% | 16,113,683 | 1,121,743 | 196,456 | 5.71 | |
LGND | Ligand Pharmaceuticals Incorpo | 08/29/2025 | 09/10/2025 | 7.17% | 16,113,683 | 1,155,180 | 145,118 | 7.96 | |
LGND | Ligand Pharmaceuticals Incorpo | 08/15/2025 | 08/26/2025 | 7.41% | 16,113,683 | 1,194,364 | 440,361 | 2.71 | |
LGND | Ligand Pharmaceuticals Incorpo | 07/31/2025 | 08/11/2025 | 5.65% | 16,215,717 | 915,900 | 221,060 | 4.14 | |
LGND | Ligand Pharmaceuticals Incorpo | 07/15/2025 | 07/24/2025 | 7.75% | 15,913,325 | 1,233,937 | 127,820 | 9.65 | |
LGND | Ligand Pharmaceuticals Incorpo | 06/30/2025 | 07/10/2025 | 7.46% | 15,913,325 | 1,187,863 | 160,715 | 7.39 | |
LGND | Ligand Pharmaceuticals Incorpo | 06/13/2025 | 06/25/2025 | 7.25% | 15,913,325 | 1,154,068 | 115,223 | 10.02 | |
LGND | Ligand Pharmaceuticals Incorpo | 05/30/2025 | 06/10/2025 | 7.72% | 15,913,325 | 1,228,133 | 106,973 | 11.48 | |
LGND | Ligand Pharmaceuticals Incorpo | 05/15/2025 | 05/27/2025 | 6.85% | 15,913,325 | 1,089,341 | 123,072 | 8.85 | |
LGND | Ligand Pharmaceuticals Incorpo | 04/30/2025 | 05/09/2025 | 7.68% | 15,900,119 | 1,221,503 | 99,579 | 12.27 | |
LGND | Ligand Pharmaceuticals Incorpo | 04/15/2025 | 04/25/2025 | 7.19% | 15,900,119 | 1,144,005 | 125,496 | 9.12 | |
LGND | Ligand Pharmaceuticals Incorpo | 03/31/2025 | 04/09/2025 | 7.38% | 13,659,206 | 1,008,698 | 135,212 | 7.46 | |
LGND | Ligand Pharmaceuticals Incorpo | 03/14/2025 | 03/25/2025 | 6.99% | 13,659,206 | 955,114 | 134,644 | 7.09 | |
LGND | Ligand Pharmaceuticals Incorpo | 02/28/2025 | 03/11/2025 | 5.71% | 13,659,206 | 780,075 | 126,463 | 6.17 | |
LGND | Ligand Pharmaceuticals Incorpo | 02/14/2025 | 02/26/2025 | 6.19% | 13,659,206 | 844,954 | 67,658 | 12.49 | |
LGND | Ligand Pharmaceuticals Incorpo | 01/31/2025 | 02/11/2025 | 6.97% | 13,659,206 | 951,520 | 80,316 | 11.85 | |
LGND | Ligand Pharmaceuticals Incorpo | 01/15/2025 | 01/27/2025 | 6.67% | 13,659,206 | 911,388 | 96,827 | 9.41 | |
LGND | Ligand Pharmaceuticals Incorpo | 12/31/2024 | 01/10/2025 | 6.59% | 13,659,206 | 900,125 | 151,674 | 5.93 | |
LGND | Ligand Pharmaceuticals Incorpo | 12/13/2024 | 12/24/2024 | 5.95% | 13,659,206 | 812,821 | 105,750 | 7.69 | |
LGND | Ligand Pharmaceuticals Incorpo | 11/29/2024 | 12/10/2024 | 5.75% | 13,659,206 | 785,702 | 112,908 | 6.96 | |
LGND | Ligand Pharmaceuticals Incorpo | 11/15/2024 | 11/26/2024 | 6.09% | 13,659,206 | 831,448 | 165,613 | 5.02 | |
LGND | Ligand Pharmaceuticals Incorpo | 10/31/2024 | 11/11/2024 | 7.05% | 13,032,783 | 918,627 | 103,027 | 8.92 | |
LGND | Ligand Pharmaceuticals Incorpo | 10/15/2024 | 10/24/2024 | 7.69% | 13,032,783 | 1,002,248 | 73,478 | 13.64 | |
LGND | Ligand Pharmaceuticals Incorpo | 09/30/2024 | 10/09/2024 | 7.64% | 13,032,783 | 996,134 | 109,917 | 9.06 | |
LGND | Ligand Pharmaceuticals Incorpo | 09/13/2024 | 09/24/2024 | 7.50% | 13,032,783 | 977,370 | 79,803 | 12.25 | |
LGND | Ligand Pharmaceuticals Incorpo | 08/30/2024 | 09/11/2024 | 7.63% | 13,032,783 | 995,023 | 104,930 | 9.48 | |
LGND | Ligand Pharmaceuticals Incorpo | 07/31/2024 | 08/09/2024 | 7.37% | 13,032,783 | 960,683 | 121,835 | 7.89 | |
LGND | Ligand Pharmaceuticals Incorpo | 07/15/2024 | 07/24/2024 | 8.64% | 12,727,486 | 1,099,115 | 157,300 | 6.99 | |
LGND | Ligand Pharmaceuticals Incorpo | 06/28/2024 | 07/10/2024 | 7.34% | 12,727,486 | 934,390 | 123,569 | 7.56 | |
LGND | Ligand Pharmaceuticals Incorpo | 06/14/2024 | 06/26/2024 | 7.36% | 12,727,486 | 936,637 | 112,280 | 8.34 | |
LGND | Ligand Pharmaceuticals Incorpo | 05/31/2024 | 06/11/2024 | 5.56% | 12,727,486 | 707,718 | 122,108 | 5.8 | |
LGND | Ligand Pharmaceuticals Incorpo | 05/15/2024 | 05/24/2024 | 6.75% | 12,727,486 | 858,712 | 181,713 | 4.73 | |
LGND | Ligand Pharmaceuticals Incorpo | 04/30/2024 | 05/09/2024 | 6.25% | 12,727,486 | 795,620 | 148,512 | 5.36 | |
LGND | Ligand Pharmaceuticals Incorpo | 04/15/2024 | 04/24/2024 | 6.50% | 12,722,187 | 826,609 | 163,335 | 5.06 | |
LGND | Ligand Pharmaceuticals Incorpo | 03/28/2024 | 04/09/2024 | 5.54% | 12,124,021 | 672,084 | 121,231 | 5.54 | |
LGND | Ligand Pharmaceuticals Incorpo | 03/15/2024 | 03/26/2024 | 7.23% | 12,124,021 | 876,303 | 259,952 | 3.37 | |
LGND | Ligand Pharmaceuticals Incorpo | 02/29/2024 | 03/11/2024 | 6.29% | 12,124,021 | 762,640 | 238,109 | 3.2 | |
LGND | Ligand Pharmaceuticals Incorpo | 02/15/2024 | 02/27/2024 | 7.56% | 11,854,692 | 896,600 | 120,565 | 7.44 | |
LGND | Ligand Pharmaceuticals Incorpo | 01/31/2024 | 02/09/2024 | 7.84% | 11,854,692 | 929,766 | 88,403 | 10.52 | |
LGND | Ligand Pharmaceuticals Incorpo | 01/12/2024 | 01/24/2024 | 7.77% | 11,854,692 | 920,671 | 115,746 | 7.95 | |
LGND | Ligand Pharmaceuticals Incorpo | 12/29/2023 | 01/10/2024 | 7.60% | 11,854,692 | 900,747 | 108,791 | 8.28 | |
LGND | Ligand Pharmaceuticals Incorpo | 12/15/2023 | 12/27/2023 | 7.54% | 11,854,692 | 893,571 | 161,049 | 5.55 | |
LGND | Ligand Pharmaceuticals Incorpo | 11/30/2023 | 12/11/2023 | 7.67% | 11,854,692 | 909,138 | 73,110 | 12.44 | |
LGND | Ligand Pharmaceuticals Incorpo | 11/15/2023 | 11/27/2023 | 7.85% | 11,854,692 | 930,178 | 120,331 | 7.73 | |
LGND | Ligand Pharmaceuticals Incorpo | 10/31/2023 | 11/09/2023 | 7.44% | 11,773,991 | 876,442 | 88,304 | 9.93 | |
LGND | Ligand Pharmaceuticals Incorpo | 10/13/2023 | 10/24/2023 | 7.17% | 11,773,991 | 844,730 | 80,820 | 10.45 |
In cerca di azioni più vendute allo scoperto?